Showing results (461-470 of 1,335) with videos related to

Sort By:
Pageof 134
Frontiers in Public Health|June 4, 2026
Self-reported problems in medication self-management in older polymedicated patients in general practiceAnneke Luegering, Tatjana Richter, Albert Lukas, et al.
Internal and Emergency Medicine|December 1, 2018
Five common errors to avoid in clinical practice: the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) Choosing Wisely CampaignElisa Stasi, Andrea Michielan, Gaetano Cristian Morreale, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 11, 2012
Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson's diseaseVincenza Bagetta, Carmelo Sgobio, Valentina Pendolino, et al.
Neurobiology of Disease|June 17, 2018
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's diseaseAlessandro Tozzi, Valentina Durante, Guendalina Bastioli, et al.
Glycobiology|December 28, 2010
N-Glycans mutations rule oligomeric assembly and functional expression of P2X3 receptor for extracellular ATPFabrizio Vacca, Nadia D'Ambrosi, Valeria Nestola, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 23, 2009
Decreased NR2B subunit synaptic levels cause impaired long-term potentiation but not long-term depressionFabrizio Gardoni, Daniela Mauceri, Matteo Malinverno, et al.
Experimental Neurology|May 7, 2009
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicityVincenzo Belcastro, Alessandro Tozzi, Michela Tantucci, et al.
International Journal of Molecular Sciences|February 10, 2024
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation DeficitsLaura Bellingacci, Jacopo Canonichesi, Miriam Sciaccaluga, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 2006
Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathwaysUlkan Kilic, Ertugrul Kilic, Anne Järve, et al.
Pageof 134